Segment and Geographic Information

3 Months Ended

Mar. 31, 2015

Segment Reporting [Abstract]

Segment and Geographic Information

Segment and Geographic Information

The Company manages its business and operations as one segment and is focused on advancing the treatment of acute and intensive care patients through the delivery of innovative, cost-effective medicines to the worldwide hospital marketplace. Revenues reported to date are derived primarily from the sales of Angiomax in the United States.

The geographic segment information provided below is classified based on the major geographic regions in which the Company operates.

	Three Months Ended March 31,
	2015				2014
	(in thousands)
Net revenue:
United States	$	120,764	95.5	%	$	167,480	94.5	%
Europe	5,090		4.0	%	8,719		4.9	%
Rest of world	662		0.5	%	1,036		0.6	%
Total net revenue	$	126,516	100.0	%	$	177,235	100.0	%

	March 31, 2015				December 31, 2014
	(in thousands)
Long-lived assets:
United States	$	1,400,153	99.4	%	$	1,218,370	99.3	%
Europe	8,634		0.6	%	8,899		0.7	%
Rest of world	—		—		15		—
Total long-lived assets	$	1,408,787	100.0	%	$	1,227,284	100.0	%